CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 237 filers reported holding CLOVIS ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $109,000 | +473.7% | 10,498 | +118.9% | 0.00% | – |
Q3 2019 | $19,000 | -70.8% | 4,795 | +11.4% | 0.00% | – |
Q2 2019 | $65,000 | -15.6% | 4,306 | +36.9% | 0.00% | -100.0% |
Q1 2019 | $77,000 | +156.7% | 3,146 | +93.4% | 0.00% | – |
Q4 2018 | $30,000 | +66.7% | 1,627 | +165.0% | 0.00% | – |
Q3 2018 | $18,000 | -86.7% | 614 | -75.9% | 0.00% | -100.0% |
Q2 2018 | $135,000 | 0.0% | 2,550 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $135,000 | +4400.0% | 2,550 | +5000.0% | 0.00% | – |
Q4 2017 | $3,000 | -76.9% | 50 | -69.5% | 0.00% | – |
Q3 2017 | $13,000 | -93.3% | 164 | -92.1% | 0.00% | -100.0% |
Q2 2017 | $194,000 | +41.6% | 2,077 | -3.4% | 0.00% | 0.0% |
Q1 2017 | $137,000 | +28.0% | 2,150 | -10.4% | 0.00% | +100.0% |
Q4 2016 | $107,000 | +48.6% | 2,400 | +20.0% | 0.00% | 0.0% |
Q3 2016 | $72,000 | +7100.0% | 2,000 | +15284.6% | 0.00% | – |
Q3 2015 | $1,000 | 0.0% | 13 | +30.0% | 0.00% | – |
Q2 2015 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
Q1 2015 | $1,000 | -91.7% | 10 | -95.2% | 0.00% | – |
Q4 2014 | $12,000 | +20.0% | 210 | 0.0% | 0.00% | – |
Q3 2014 | $10,000 | -95.4% | 210 | -96.0% | 0.00% | -100.0% |
Q2 2014 | $216,000 | – | 5,225 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |